领先的血栓切除设备制造商Penumbra Inc（股票代码：PEN）在周三夜盘交易中股价大涨11.82%，这一显著涨幅源于公司发布的强劲第二季度财报。
根据公司公告，Penumbra在2025年第二季度实现收入3.395亿美元，同比增长13.4%，超过分析师预期的3.2777亿美元。调整后每股收益达到0.86美元，同样超出市场普遍预期的0.82美元。这一亮眼业绩主要得益于公司美国血栓切除业务的强劲表现，特别是美国静脉血栓栓塞（VTE）业务同比增长42%。
值得注意的是，Penumbra还上调了2025年全年收入指引至13.55亿美元至13.7亿美元区间，高于此前分析师预期的13.54亿美元。公司维持了美国血栓切除业务相比2024年水平增长20%至21%的指引。这一积极展望进一步提振了投资者信心，推动股价大幅上涨。分析师普遍对公司保持看好态度，给予"买入"评级，并将12个月目标价中位数设定在320美元，较此前收盘价有约28.1%的上涨空间。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.